PublicationDataRheumPredictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic DrugsDownload
PublicationDataRheumDisease Activity in Rheumatoid Arthritis Patients Initiating Anti-Obesity Medication in a Longitudinal US-Based Real-World CohortDownload
PublicationAIRheumLessons Learned from the Development of Machine Learning Models to Estimate Validated Measures of Disease Activity and Symptom Severity Using Real-World Data for Four Chronic ConditionsDownload
PublicationAIRheumMachine Learning Models to Estimate Disease Activity Measures in Real-World Data Sources: Lessons Learned from Four Autoimmune DiseasesDownload
PublicationDataRheumImpact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis PatientsDownload
PublicationDataRheumImpact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Rheumatoid Arthritis PatientsDownload
PublicationDataRheumCharacterization of Non-radiographic Axial Spondyloarthritis Patients and the Burden of Disease in Routine Clinical PracticeDownload
PublicationDataRheumEffect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical PracticeDownload
PublicationDataRheumA Cross-Sectional Study of Rheumatoid Arthritis (RA) Diagnoses in Patients with Systemic Lupus Erythematosus (SLE)Download
PublicationAIRheumValidation of a Machine Learning Approach to Estimate Clinical Disease Activity Index Scores for Rheumatoid ArthritisRead more
PublicationDataRheumCharacterizing Non-Response to Methotrexate Monotherapy Among Rheumatoid Arthritis Patients in a Large Real-World Longitudinal CohortDownload
PublicationDataRheumPatient Characteristics and Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: The OM1 RA RegistryDownload
PublicationAIDataRheumPrediction of Non-Response to First-Line Methotrexate Treatment in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine LearningDownload
PublicationAIDataRheumValidation of a Machine Learning Approach to Estimate Systemic Lupus Erythematosus Disease Activity Index Score Categories and Application in a Real-World DatasetDownload
PublicationAIRheumComparison of an AI–Enabled Patient Decision Aid vs Educational Material on Decision Quality, Shared Decision-Making, Patient Experience, and Functional Outcomes in Adults with Knee Osteoarthritis: A Randomized Clinical TrialRead more
PublicationDataRheumHarmonized Outcome Measures for Use in Degenerative Lumbar Spondylolisthesis Patient Registries and Clinical PracticeRead more
PublicationDataRheumCharacterizing Patients Initiating Abaloparatide, Teriparatide, or Denosumab in a Real-World Setting: a US Linked Claims and EMR Database AnalysisDownload
PublicationDataRheumAn Evaluation of Real-World Use of Biologics in Rare Systemic Vasculitides During Routine Clinical Care in the USDownload
PublicationDataRheumAssessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus CohortDownload
PublicationDataRheumJoint Involvement and Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Calculation of Swollen to Tender Joint Count Ratio in a Real-World Cohort in the U.S.Download
PublicationDataRheumPredictors of Improvement in Tender Joint Counts Among Patients with Systemic Lupus Erythematosus in A Large, Representative US-Based Real-World Registry Cohort. ISPOR Annual Conference. Orlando, FL, May 2020.Download
PublicationDataRheumCharacteristics and Disease Management in a Large Real-World Lupus Nephritis Cohort in the U.S.Download
PublicationDataRheumPatient Characteristics and Management Of Juvenile Idiopathic Arthritis (JIA) In a Large, Representative Real-World CohortDownload
PublicationDataRheumAvailability of Disease Activity Measures from Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World Registry CohortDownload
PublicationDataRheumImprovements in Disease Activity Scores Associated with bDMARD use by Rheumatoid Arthritis Patients in a Large US-Based Real World CohortDownload
PublicationDataRheumPatient Characteristics and Current Management of Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World CohortDownload
PublicationDataRheumAge and Gender Differences in Comorbidities among Patients with Rheumatoid Arthritis in a Large US-Based Real World CohorDownload
PublicationDataRheumTreatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the U.S.Download
PublicationDataRheumInitiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World CohortDownload
PublicationDataRheumComparison of Improvements in Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real World CohortRead more
PublicationDataRheumInitiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Next Generation RegistryDownload
PublicationDataRheumPatient Reported Outcomes and Changes in DMARD Therapy for Rheumatoid Arthritis in Routine Clinical PracticeDownload
Webinar & VideoAIDataRheumFrom Subtyping to Measuring and Predicting Outcomes: How AI is Changing Rheumatology and Immunology ResearchRead more
News & ArticleAIRheumOM1 Rheumatoid Arthritis Dataset Rated High Quality as Cornerstone AI Partnership Speeds Future Quality ReviewsRead more
Webinar & VideoDataRheumBehind the Insights: Ep 05 Rheumatoid Arthritis Remission with Chandra Gopalakrishnan, MD, MPHRead more
News & ArticleAIRheumPeek Behind the Poster: Machine learning to estimate disease activity measures for autoimmune diseases in real-world data sourcesRead more
News & ArticleDataAIRheumAmplifying lupus disease activity with real-world data and machine learningRead more
News & ArticleDataAIRheumRAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA SeverityRead more
News & ArticleDataRheumKazuki Yoshida, MD, MPH, ScD: Methotrexate Access in the Post-Roe v Wade EraRead more
News & ArticleDataRheumOM1 Rheumatoid Arthritis Registry Reaches More Than 200,000 Patients Prospectively Followed With Deep Clinical DataRead more
News & ArticleDataRheumOM1 Giant Cell Arteritis Registry Reaches More Than 5,000 Patients Prospectively Followed With Deep Clinical DataRead more
News & ArticleDataRheumOM1 Rheumatoid Arthritis Registry Reaches More Than 100,000 Patients Prospectively Followed with Deep Clinical DataRead more
